Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Genomics, |
RCV001281015 | SCV001468419 | uncertain significance | Diabetes mellitus type 1; Insulin-dependent diabetes mellitus secretory diarrhea syndrome | 2020-08-04 | criteria provided, single submitter | clinical testing | FOXP3 NM_014009.3 exon 2 p.Asp34Glu (c.102C>A): This variant has not been reported in the literature and is not present in large control databases. This variant Glutamic acid (Glu) is present in several species including mammals ; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Center for Genomics, |
RCV003224546 | SCV003919990 | uncertain significance | Insulin-dependent diabetes mellitus secretory diarrhea syndrome | 2021-03-30 | criteria provided, single submitter | clinical testing | FOXP3 NM_014009.3 exon 2 p.Asp34Glu (c.102C>A): This variant has not been reported in the literature and is not present in large control databases. This variant Glutamic acid (Glu) is present in several species including mammals ; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |